Hormonal drug therapy for sexual offenders with paraphilic disorders

Authors

  • Victor Suárez Moreno Magister en Salud Pública; Instituto Nacional de Salud, Lima, Perú; Universidad Nacional Mayor de San Marcos, Lima, Perú
  • Patricia Caballero Ñopo Magister en Ciencias en Salud Pública; Instituto Nacional de Salud, Lima, Perú; Universidad Nacional Mayor de San Marcos, Lima, Perú
  • Karen Huamán Sánchez Licenciada en enfermería; Instituto Nacional de Salud, Lima, Perú
  • Nora Reyes Puma Magister en Salud Pública; Instituto Nacional de Salud, Lima, Perú; Universidad Nacional Mayor de San Marcos, Lima, Perú

DOI:

https://doi.org/10.15381/anales.v79i3.15317

Keywords:

Sex offenses, Castration, Paraphilic disorders, Androgen antagonists, Gonadotropin-releasing hormone

Abstract

through hormonal therapy. The aim of this review is to evaluate the effects of anti-androgen therapy on sexual offenders with paraphilic disorders. We searched for systematic reviews and clinical practice guidelines on anti-androgen therapy. Two systematic reviews and a clinical practice guide were selected whose evidence corresponds to case reports and observational studies. Primary outcome, sexual relapse, has only been evaluated in two comparative studies with medroxyprogesterone. Small number of participants and high percentage of dropouts do not allow conclusions to be drawn as to efficacy. Frequent adverse effects were reported. Available evidence is scant and of low quality on the efficacy of hormonal therapy with antiandrogens steroids and GnRH analogs in patients with paraphilic disorders.

Downloads

Published

2018-10-09

Issue

Section

Artículos de Revisión

How to Cite

1.
Suárez Moreno V, Caballero Ñopo P, Huamán Sánchez K, Reyes Puma N. Hormonal drug therapy for sexual offenders with paraphilic disorders. An Fac med [Internet]. 2018 Oct. 9 [cited 2024 Jul. 17];79(3):233-7. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15317